C4 Therapeutics, Inc. (CCCC) Operating cash flow 2019–2025
C4 Therapeutics, Inc. (CCCC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$98.7MFY2025 · since FY2019: $55.6M → -$98.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$98.7M | -51.5% |
| FY2024 | -$65.2M | +39.0% |
| FY2023 | -$106.8M | -0.8% |
| FY2022 | -$105.9M | -21.8% |
| FY2021 | -$87.0M | -29.3% |
| FY2020 | -$67.2M | -220.9% |
| FY2019 | $55.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice